Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: ANTITHROMBIN, . Treffer: 59

2022

Englisch, C; Konigsbrugge, O; Nopp, S; Moik, F; Quehenberger, P; Preusser, M; Pabinger, I; Ay, C Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
INT J MOL SCI. 2022; 23(24): 15770 Doi: 10.3390/ijms232415770 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Schwaiger, M; Edmondson, SJ; Rabensteiner, J; Prüller, F; Gary, T; Zemann, W; Wallner, J Gender-specific differences in haemostatic parameters and their influence on blood loss in bimaxillary surgery.
Clin Oral Investig. 2022; 26(4):3765-3779 Doi: 10.1007/s00784-021-04347-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

Mangge, H; Herrmann, M; Meinitzer, A; Pailer, S; Curcic, P; Sloup, Z; Holter, M; Prüller, F Increased Kynurenine Indicates a Fatal Course of COVID-19.
Antioxidants (Basel). 2021; 10(12): Doi: 10.3390/antiox10121960 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2020

Goswami, N; Brix, B; Roessler, A; Koestenberger, M; Reibnegger, G; Cvirn, G Menstrual Phase Affects Coagulation and Hematological Parameters during Central Hypovolemia.
J Clin Med. 2020; 9(10): Doi: 10.3390/jcm9103118 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Goswami, N; Taucher, AA; Brix, B; Roessler, A; Koestenberger, M; Reibnegger, G; Cvirn, G Coagulation Changes during Central Hypovolemia across Seasons.
J Clin Med. 2020; 9(11): Doi: 10.3390/jcm9113461 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2019

Kneihsl, M; Gattringer, T; Bisping, E; Scherr, D; Raggam, R; Mangge, H; Enzinger, C; Fandler-Höfler, S; Eppinger, S; Hermetter, C; Bucnik, B; Poltrum, B; Niederkorn, K; Fazekas, F Blood Biomarkers of Heart Failure and Hypercoagulation to Identify Atrial Fibrillation-Related Stroke.
Stroke. 2019; 50(8):2223-2226 Doi: 10.1161/STROKEAHA.119.025339
Web of Science PubMed FullText FullText_MUG

 

2017

Cvirn, G; Kneihsl, M; Rossmann, C; Paar, M; Gattringer, T; Schlagenhauf, A; Leschnik, B; Koestenberger, M; Tafeit, E; Reibnegger, G; Trozic, I; Rössler, A; Fazekas, F; Goswami, N Orthostatic Challenge Shifts the Hemostatic System of Patients Recovered from Stroke toward Hypercoagulability.
Front Physiol. 2017; 8(4):12-12 Doi: 10.3389/fphys.2017.00012 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Zirlik, A; Bode, C Vitamin K antagonists: relative strengths and weaknesses vs. direct oral anticoagulants for stroke prevention in patients with atrial fibrillation.
J THROMB THROMBOLYS. 2017; 43(3): 365-379. Doi: 10.1007/s11239-016-1446-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Cimenti, C; Schlagenhauf, A; Leschnik, B; Fröhlich-Reiterer, E; Jasser-Nitsche, H; Haidl, H; Suppan, E; Weinhandl, G; Leberl, M; Borkenstein, M; Muntean, WE Only minor changes in thrombin generation of children and adolescents with type 1 diabetes mellitus - A case-control study.
Thromb Res. 2016; 148(8):45-49 Doi: 10.1016/j.thromres.2016.10.016
Web of Science PubMed FullText FullText_MUG

 

2015

Cvirn, G; Waha, JE; Ledinski, G; Schlagenhauf, A; Leschnik, B; Koestenberger, M; Tafeit, E; Hinghofer-Szalkay, H; Goswami, N Bed rest does not induce hypercoagulability.
Eur J Clin Invest. 2015; 45(1):63-69 Doi: 10.1111/eci.12383
Web of Science PubMed FullText FullText_MUG

 

2013

Cimenti, C; Schlagenhauf, A; Leschnik, B; Schretter, M; Tschakert, G; Gröschl, W; Seibert, FJ; Hofmann, P; Muntean, WE Low endogenous thrombin potential in trained subjects.
Thromb Res. 2013; 131(6):e281-e285 Doi: 10.1016/j.thromres.2013.04.009
Web of Science PubMed FullText FullText_MUG

 

2012

Cvirn, G; Schlagenhauf, A; Leschnik, B; Koestenberger, M; Roessler, A; Jantscher, A; Vrecko, K; Juergens, G; Hinghofer-Szalkay, H; Goswami, N Coagulation Changes during Presyncope and Recovery.
PLoS One. 2012; 7(8):e42221-e42221 Doi: 10.1371/journal.pone.0042221 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Hoerl, G; Tafeit, E; Leschnik, B; Wagner, T; Muntean, W; Juergens, G; Koestenberger, M; Cvirn, G Cardiac catheterization: haemostatic changes in pediatric versus adult patients.
J Thromb Thrombolysis. 2011; 32(3):372-377 Doi: 10.1007/s11239-011-0606-5
Web of Science PubMed FullText FullText_MUG

 

Oberbach, A; Bluher, M; Wirth, H; Till, H; Kovacs, P; Kullnick, Y; Schlichting, N; Tomm, JM; Rolle-Kampczyk, U; Murugaiyan, J; Binder, H; Dietrich, A; von Bergen, M; Combined Proteomic and Metabolomic Profiling of Serum Reveals Association of the Complement System with Obesity and Identifies Novel Markers of Body Fat Mass Changes.
J PROTEOME RES. 2011; 10(10): 4769-4788. Doi: 10.1021/pr2005555
Web of Science PubMed FullText FullText_MUG

 

2010

Krisper, P; Tiran, B; Fliser, D; Haditsch, B; Stadlbauer, V; Otto, R; Ernst, T; Kretschmer, U; Stauber, RE; Haller, H; Holzer, H; Manns, MP; Rifai, K Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with prometheus.
Artif Organs. 2010; 34(1): 84-88. Doi: 10.1111/j.1525-1594.2009.00793.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Silbernagel, G; Schmalzing, M; Riessen, R; Koetter, I Sepsis with acral necrosis in a patient with Sharp syndrome - case 8/2010].
Dtsch Med Wochenschr. 2010; 135(36):1741-1741 Doi: 10.1055/s-0030-1247615 (- Case Report)
PubMed FullText FullText_MUG

 

2009

Rek, A; Krenn, E; Kungl, AJ Therapeutically targeting protein-glycan interactions.
Br J Pharmacol. 2009; 157(5): 686-94. Doi: 10.1111/j.1476-5381.2009.00226.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Koestenberger, M; Cvirn, G; Nagel, B; Rosenkranz, A; Leschnik, B; Gamillscheg, A; Beitzke, A; Muntean, W Thrombin generation determined by calibrated automated thrombography (CAT) in pediatric patients with congenital heart disease.
Thromb Res. 2008; 122(1): 13-19. Doi: 10.1016/j.thromres.2007.08.016
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Koestenberger, M; Cvirn, G; Rosenkranz, A; Leschnik, B; Raith, W; Muntean, W Thrombin generation in paediatric patients with congenital heart disease. Determination by calibrated automated thrombography.
HAMOSTASEOLOGIE. 2008; 28 Suppl 1(12): S61-S66. Doi: 10.1055/s-0037-1617119
Web of Science PubMed FullText FullText_MUG

 

Rosenkranz, A; Hiden, M; Leschnik, B; Weiss, EC; Schlembach, D; Lang, U; Gallistl, S; Muntean, W Calibrated automated thrombin generation in normal uncomplicated pregnancy.
Thromb Haemost. 2008; 99(2): 331-337. Doi: 10.1160/TH07-05-0359
Web of Science PubMed FullText FullText_MUG

 

Rosenkranz, A; Koestenberger, M; Novak, M; Cvirn, G; Leschnik, B; Gamillscheg, A; Beitzke, A; Muntean, W Pediatric patients with congenital heart disease: thrombin generation measured by calibrated automated thrombography.
Blood Coagul Fibrinolysis. 2008; 19(5): 389-393. Doi: 10.1097/MBC.0b013e3282fe7224
Web of Science PubMed FullText FullText_MUG

 

2007

Cvirn, G; Cimenti, C; Kutschera, J; Ferstl, U; Wagner, T; Muntean, W; Jurgens, G; Gallistl, S; Koestenberger, M Anticoagulant action of melagatran: a comparison between neonates and adults using calibrated automated thrombography (CAT).
Eur J Pediatr. 2007; 166(5): 427-431. Doi: 10.1007/s00431-006-0253-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Niedermayr, M; Schramm, W; Kamolz, L; Andel, D; Römer, W; Hoerauf, K; Zimpfer, M; Andel, H Antithrombin deficiency and its relationship to severe burns.
Burns. 2007; 33(2):173-178 Doi: 10.1016/j.burns.2006.06.011
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Fritsch, P; Cvirn, G; Cimenti, C; Baier, K; Gallistl, S; Koestenberger, M; Roschitz, B; Leschnik, B; Muntean, W Thrombin generation in factor VIII-depleted neonatal plasma: nearly normal because of physiologically low antithrombin and tissue factor pathway inhibitor.
J Thromb Haemost. 2006; 4(5): 1071-1077. Doi: 10.1111/j.1538-7836.2006.01947.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Koestenberger, M; Gallistl, S; Bettina, L; Cimenti, C; Kutschera, J; Cvirn, G Effects of melagatran on activated partial thromboplastin time and on ecarin clotting time in cord versus adult plasma.
Blood Coagul Fibrinolysis. 2006; 17(8): 677-680. Doi: 10.1097/01.mbc.0000252604.63142.e0
Web of Science PubMed FullText FullText_MUG

 

2005

Koestenberger, M; Gallistl, S; Cvirn, G; Baier, K; Leschnik, B; Muntean, W Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.
THROMB RES. 2005; 115(1-2): 135-142. Doi: 10.1016/j.thromres.2004.07.003
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Koestenberger, M; Gallistl, S; Muntean, W; Leschnik, B; Fritsch, P; Cvirn, G Additive effects of anticoagulants: recombinant human activated protein C and heparin or melagatran, in tissue factor-activated umbilical-cord plasma.
Thromb Haemost. 2005; 94(1): 69-74. Doi: 10.1267/THRO05010069
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2004

Cvirn, G; Gallistl, S; Koestenberger, M; Baier, K; Fritsch, P; Greilberger, J; Jürgens, G; Muntean, W The anticoagulant action of recombinant human activated protein C (rhAPC, Drotrecogin alpha activated): comparison between cord and adult plasma.
THROMB HAEMOST. 2004; 91(5): 912-918. Doi: 10.1267/THRO04050912
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Koestenberger, M; Cvirn, G; Gallistl, S; Baier, K; Leschnik, B; Muntean, W Drotrecogin alfa (activated, Xigris) in combination with heparin or melagatran: an in vitro investigation.
J THROMB THROMBOLYSIS. 2004; 18(1): 5-10. Doi: 10.1007/s11239-004-0167-y
Web of Science PubMed FullText FullText_MUG

 

Koestenberger, M; Cvirn, G; Gallistl, S; Muntean, W Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time.
BLOOD COAGULAT FIBRINOL. 2004; 15(8): 693-697. Doi: 10.1097/00001721-200412000-00010
Web of Science PubMed FullText FullText_MUG

 

2003

Cvirn, G; Gallistl, S; Leschnik, B; Muntean, W Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates.
J THROMB HAEMOST. 2003; 1(2): 263-268. Doi: 10.1046%2Fj.1538-7836.2003.00081.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Cvirn, G; Gallistl, S; Rehak, T; Jürgens, G; Muntean, W Elevated thrombin-forming capacity of tissue factor-activated cord compared with adult plasma.
J THROMB HAEMOST. 2003; 1(8): 1785-1790. Doi: 10.1046%2Fj.1538-7836.2003.00320.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2001

Cvirn, G; Gallistl, S; Muntean, W Effects of alpha(2)-macroglobulin and antithrombin on thrombin generation and inhibition in cord and adult plasma.
Thromb Res. 2001; 101(3):183-191 Doi: 10.1016%2FS0049-3848%2800%2900389-3
Web of Science PubMed FullText FullText_MUG

 

2000

Ilias, W; List, W; Decruyenaere, J; Lignian, H; Knaub, S; Schindel, F; Keinecke, HO; Heinrichs, H; Thijs, LG Antithrombin III in patients with severe sepsis: a pharmacokinetic study.
Intensive Care Med. 2000; 26(6):704-715 Doi: 10.1007%2Fs001340051236
Web of Science PubMed FullText FullText_MUG

 

März, W; Nauck, M; Wieland, H The molecular mechanisms of inherited thrombophilia.
Z Kardiol. 2000; 89(7):575-586 Doi: 10.1007/s003920070206
Web of Science PubMed FullText FullText_MUG

 

1999

Cvirn, G; Gallistl, S; Muntean, W Effects of antithrombin and protein C on thrombin generation in newborn and adult plasma.
Thromb Res. 1999; 93(4):183-190 Doi: 10.1016%2FS0049-3848%2898%2900181-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Gallistl, S; Reitinger, T; Linhart, W; Muntean, W The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease.
J Pediatr Orthop. 1999; 19(1): 82-83. Doi: 10.1097/00004694-199901000-00018
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Campbell, RW; Wallentin, L; Verheugt, FW; Turpie, AG; Maseri, A; Klein, W; Cleland, JG; Bode, C; Becker, R; Anderson, J; Bertrand, ME; Conti, CR Management strategies for a better outcome in unstable coronary artery disease.
Clin Cardiol. 1998; 21(5):314-322 Doi: 10.1002/clc.4960210504 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gallistl, S; Mangge, H; Neuwirth, G; Muntean, W Activation of the haemostatic system in children with juvenile rheumatoid arthritis correlates with disease activity.
Thromb Res. 1998; 92(6):267-272 Doi: 10.1016/S0049-3848(98)00145-5
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Locker, GJ; Staudinger, T; Knapp, S; Laczika, KF; Burgmann, H; Urlicic, A; Wagner, A; Metnitz, P; Knoebl, P; Schuster, E; Frass, M Prostaglandin E1 inhibits platelet decrease after massive blood transfusions during major surgery: influence on coagulation cascade?
J Trauma. 1997; 42(3):525-531 Doi: 10.1097/00005373-199703000-00022
Web of Science PubMed FullText FullText_MUG

 

Urlesberger, B; Zobel, G; Rödl, S; Dacar, D; Friehs, I; Leschnik, B; Muntean, W Activation of the clotting system: heparin-coated versus non coated systems for extracorporeal circulation.
INT J ARTIF ORGANS 1997 20: 708-712. Doi: 10.1177/039139889702001211
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Urlesberger, B; Zobel, G; Zenz, W; Kuttnig-Haim, M; Maurer, U; Reiterer, F; Riccabona, M; Dacar, D; Gallisti, S; Leschnik, B; Muntean, W Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants.
J Pediatr. 1996; 129(2):264-268 Doi: 10.1016/S0022-3476(96)70252-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1995

Dittel, M; Haushofer, A; Spiel, R; Halbmayer, WM; Prachar, H; Fischer, M; Mlczoch, J Changes in antithrombin III, prothrombin fragment 1 + 2 and thrombin-antithrombin III complex following implantation of a coronary Palmaz-Schatz stent.
Z Kardiol. 1995; 84(1):22-29
Web of Science PubMed

 

Zenz, W; Muntean, W; Gallistl, S; Leschnik, B; Beitzke, A Inherited resistance to activated protein C in a boy with multiple thromboses in early infancy.
Eur J Pediatr. 1995; 154(4):285-288 Doi: 10.1007%2Fs004310050290 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1994

Gallistl, S; Muntean, W Thrombin-Hirudin complex formation, thrombin-antithrombin III complex formation, and thrombin generation after intrinsic activation of plasma.
Thromb Haemost. 1994; 72(3):387-392 Doi: 10.1055/s-0038-1648876
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Haushofer, A; Halbmayer, WM; Dittel, M; Prachar, H; Mlczoch, J; Fischer, M Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.
Blood Coagul Fibrinolysis. 1994; 5(5):697-706 Doi: 10.1097/00001721-199410000-00004
Web of Science PubMed FullText FullText_MUG

 

Latin, V; Jankovic, D; Cervar, M; Bernt, T; Fuduric, I Antithrombin III in fetuses and newborn children.
Acta Obstet Gynecol Scand. 1994; 73(1): 74-75. Doi: 10.3109/00016349409013400
Web of Science PubMed FullText FullText_MUG

 

1993

Halbmayer, WM; Haushofer, A; Toth, E Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters.
Wien Med Wochenschr. 1993; 143(5):95-98
PubMed

 

Lippe, IT; Sametz, W; Sabin, K; Holzer, P Inhibitory role of capsaicin-sensitive afferent neurons and nitric oxide in hemostasis.
Am J Physiol. 1993; 265(6 Pt 2):H1864-H1868 Doi: 10.1152/ajpheart.1993.265.6.H1864
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Pilger, E; Obernosterer, A; Stark, G; Decrinis, M Etiology of deep venous thrombosis of the leg
ACTA MED AUST. 1991; 18(3): 68-72.
Web of Science PubMed

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum